IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$13.6M
3
+$9.11M
4
SAGE
Sage Therapeutics
SAGE
+$6.18M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.32M

Top Sells

1
+$12.7M
2
+$11.7M
3
+$11.3M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.2M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
– –
-180
77
– –
-74
78
– –
0
79
– –
-49,372
80
– –
-143,214
81
– –
0
82
– –
-375,000
83
– –
0
84
– –
-246,554
85
– –
-41,900
86
– –
0
87
– –
0
88
– –
0
89
– –
0
90
– –
-60,000
91
– –
0
92
– –
-132,014
93
– –
-29
94
– –
-31,694
95
– –
-21,192
96
– –
0
97
– –
-25
98
– –
-45,516
99
– –
0
100
– –
0
2 3
4
5 6